Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

SRRK Insider Trading

Scholar Rock Holding Corp | Biological Products, (No Diagnostic Substances)

Comprehensive Trading Performance Summary

The investment history of corporate insiders at Scholar Rock Holding Corp provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Biological Products, (No Diagnostic Substances) sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2022-06-24 23:27 2022-06-22 Nashat Amir Director BUY $4.90 1,197,992 $5,870,161 206,897 +100.0%
2021-11-16 05:28 2021-11-11 Myles Edward H Officer - Chief Financial Officer OPT+S $35.14 78,301 $2,751,301 24,150 0.0%
2021-10-05 15:15 2021-10-01 FLIER JEFFREY S. Director SELL $30.89 6,000 $185,329 22,272 -21.2%
2021-09-21 23:46 2021-09-20 FLIER JEFFREY S. Director SELL $34.09 500 $17,045 9,013 -5.3%
2021-07-28 23:17 2021-07-26 FLIER JEFFREY S. Director SELL $31.66 6,000 $189,954 28,272 -17.5%
2021-03-18 00:03 2021-03-15 Gilman Michael Director SELL $65.59 4,696 $307,998 37,459 -11.1%
2021-02-11 15:14 2021-02-08 Gilman Michael Director SELL $65.06 1,804 $117,361 42,155 -4.1%
2021-01-29 01:47 2021-01-26 Carven Gregory John Officer - Head of Research OPT+S $58.44 55,874 $3,265,221 26,860 0.0%
2021-01-29 05:53 2021-01-26 Carven Gregory John Officer - Head of Research SELL $57.26 22,707 $1,300,089 32,734 -41.0%
2021-01-29 01:48 2021-01-26 Gilman Michael Director OPT+S $59.26 3,501 $207,469 43,959 0.0%
2018-06-01 04:42 2018-05-29 Nashat Amir Director, 10% owner BUY $14.00 142,857 $1,999,998 156,395 +1,055.2%
2018-06-01 04:43 2018-05-29 Polaris Venture Management Co. VI, L.L.C. 10% owner BUY $14.00 142,857 $1,999,998 156,395 +1,055.2%
2018-06-01 04:41 2018-05-29 SPRINGER TIMOTHY A Director, 10% owner BUY $14.00 71,428 $999,992 3,273,519 +2.2%
2018-06-01 04:41 2018-05-29 Artal International S.C.A. 10% owner BUY $14.00 450,000 $6,300,000 450,000 +100.0%
SHOW ENTRIES

How to Interpret $SRRK Trades

Not every insider transaction in Scholar Rock Holding Corp is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $SRRK shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for SRRK

Insider activity data for Scholar Rock Holding Corp is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $SRRK, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.